2025
SJR Q2
JCR Q4 · 1
155 matched articles
SCIE
Journal detail
Blood Pressure Monitoring
- Publisher
- Lippincott Williams and Wilkins
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1359523714735725
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,316
- Quartile Q2
- H-Index 70
- Cites/doc 1,06
- Docs (3y) 197
- Cites (3y) 194
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1
- 5Y JIF 1,1
- JCI 0,29
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Advanced and Specialized Nursing Q2
- Assessment and Diagnosis Q3
- Cardiology and Cardiovascular Medicine Q3
- Internal Medicine Q3
- Medicine (miscellaneous) Q3
Areas
- Medicine
- Nursing
WoS categories
- Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q4 | 0,316 | 1 | 1,1 | 0,29 | Q4 | 70 |
| 2024 | Q2 | Q4 | 0,33 | 1,2 | 1,1 | 0,34 | Q4 | 67 |
| 2023 | Q2 | Q4 | 0,345 | 1,2 | 1,2 | 0,31 | Q4 | 67 |
| 2022 | Q2 | Q4 | 0,28 | 1,3 | 1,1 | 0,28 | Q4 | 67 |
| 2021 | Q2 | Q4 | 0,352 | 1,4 | 1,2 | 0,27 | Q4 | 67 |
| 2020 | Q1 | Q4 | 0,446 | 1,4 | 1,4 | 0,29 | Q4 | 67 |
| 2019 | Q1 | Q4 | 0,42 | 1,1 | 1,2 | 0,28 | Q4 | 67 |
| 2018 | — | Q4 | — | 1 | 1,2 | 0,29 | Q4 | — |
| 2017 | Q1 | Q4 | 0,537 | 1,2 | 1,3 | 0,29 | Q4 | 67 |
| 2016 | Q1 | Q4 | 0,593 | 1,2 | 1,4 | — | — | 67 |
| 2015 | Q1 | Q4 | 0,477 | 1,1 | 1,5 | — | — | 67 |
| 2014 | Q1 | Q4 | 0,486 | 1,5 | 1,5 | — | — | 67 |
| 2013 | Q1 | Q4 | 0,912 | 1,2 | 1,6 | — | — | 67 |
| 2012 | Q1 | Q3 | 0,821 | 1,8 | 1,5 | — | — | 67 |
| 2011 | Q1 | Q3 | 0,863 | 1,5 | 1,8 | — | — | 67 |
| 2010 | Q1 | Q4 | 0,779 | 1,2 | 1,5 | — | — | 67 |
| 2009 | — | Q4 | — | 1,2 | 1,6 | — | — | — |
| 2008 | — | Q3 | — | 1,6 | 2 | — | — | — |
| 2007 | — | Q3 | — | 1,6 | 1,9 | — | — | — |
| 2006 | — | Q3 | — | 1,4 | — | — | — | — |
| 2005 | — | Q3 | — | 1,5 | — | — | — | — |
| 2004 | — | Q3 | — | 1,8 | — | — | — | — |
| 2003 | — | Q3 | — | 1,3 | — | — | — | — |
| 2002 | — | Q3 | — | 1,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 86/100 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 81/98 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 77/96 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 64/68 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 63/67 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 61/65 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 63/65 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 62/65 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 60/65 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 54/63 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 57/63 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 48/60 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 55/65 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 41/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 46/68 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 52/68 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 47/61 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 38/56 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 32/54 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 33/52 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 32/51 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 26/51 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 30/52 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 27/52 |